US 2003/0144206 A1 · Combined use of a GLP-1 compound and modulator of diabetic late complications

Abstract

Methods and uses for treatment of diabetic late complications comprising administration of a GLP-1 compound and a modulator of diabetic complications.

Claims54

Dependent claims

A method for treating diabetic late complications in a patient in need thereof, said method comprising administration to said patient of an effective amount of a glucagon-like peptide 1 (GLP-1) compound and an effective amount of a modulator of a diabetic late complication.

Dependencies are inferred from the claim text.

Facts

Application

10/328,282Filed 23 Dec 2002

Priority

DK PA 2001 0196929 Dec 2001

Published

31 Jul 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 38/26
Hormones: glucagons
A61K 38/556
Protease inhibitors: angiotensin converting enzyme inhibitors

Abstract

Methods and uses for treatment of diabetic late complications comprising administration of a GLP-1 compound and a modulator of diabetic complications.

Claims54

Dependent claims

Dependencies are inferred from the claim text.

Combined use of a GLP-1 compound and modulator of diabetic late complications

Life of this patent

Abstract

Claims54

Combined use of a GLP-1 compound and modulator of diabetic late complications

Life of this patent

Abstract

Claims54